Research
Hormonal
GLP-1 receptor agonists provide glycemic and complication-risk reduction benefits for individuals with type 2 diabetes.
Practitioners can consider GLP-1 receptor agonists as effective treatment options for managing glycemic levels and reducing complications in type 2 diabetes patients.
StrongSupportsmedium confidence
GLP-1 receptor agonists provide glycemic and complication-risk reduction benefits for individuals with type 2 diabetes.
Why this rating
The claim is based on landmark trials and current data discussed in the abstract.
Source
Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes
Lidiya Kukova et al. · Expert Opinion on Drug Metabolism & Toxicology · 2024
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →